BMJ Open Diabetes Research & Care: 11 (3)

Cardiovascular and metabolic risk

Efficacy and safety of luseogliflozin in Caucasian patients with type 2 diabetes: results from a phase III, randomized, placebo-controlled, clinical trial (16 June, 2023)
Marina Shestakova, Boris Kvasnikov, Ekaterina Erina, Elena Isachenko, Alexander Andreev
Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering (13 June, 2023)
David M Charytan, Kenneth W Mahaffey, Meg J Jardine, Christopher P Cannon, Bruce Neal, Hiddo J Lambers Heerspink, Rajiv Agarwal, George L Bakris, Dick de Zeeuw, Adeera Levin, Carol Pollock, Hong Zhang, Bernard Zinman, Norman Rosenthal, Vlado Perkovic, Gian Luca Di Tanna, Jie Yu, Kris Rogers, Clare Arnott, David C Wheeler
Long-term effect of intensive lifestyle intervention on cardiometabolic risk factors and microvascular complications in patients with diabetes in real-world clinical practice: a 10-year longitudinal study (22 May, 2023)
Shaheen Tomah, Hongxia Zhang, Marwa Al-Badri, Tareq Salah, Shilton Dhaver, Abdelrahman Khater, Mhd Wael Tasabehji, Osama Hamdy
Trends in glycemic, blood pressure, and lipid control in adults with diabetes in Switzerland: the CoLaus|PsyCoLaus Study (15 May, 2023)
Abdullah Alkandari, Julien Vaucher, Pedro Marques-Vidal

Epidemiology/Health services research

Blood glucose, blood pressure, and cholesterol testing among adults with diabetes before and during the COVID-19 pandemic, USA, 2019 vs 2021 (28 June, 2023)
Sarah S Casagrande, Jean M Lawrence
Subsidised housing and diabetes mortality: a retrospective cohort study of 10 million low-income adults in Brazil (22 June, 2023)
Renzo Flores-Ortiz, Rosemeire L Fiaccone, Alastair Leyland, Christopher Millett, Thomas Hone, Maria Inês Schmidt, Andrêa J F Ferreira, Maria Y Ichihara, Camila Teixeira, Mauro N Sanchez, Julia Pescarini, Estela M L Aquino, Deborah C Malta, Gustavo Velasquez-Melendez, Juliane Fonseca de Oliveira, Peter Craig, Rita C Ribeiro-Silva, Mauricio L Barreto, Srinivasa Vittal Katikireddi
Prevalence and predictive modeling of undiagnosed diabetes and impaired fasting glucose in Taiwan: a Taiwan Biobank study (16 June, 2023)
Ren-Hua Chung, Shao-Yuan Chuang, Ying-Erh Chen, Guo-Hung Li, Chang-Hsun Hsieh, Hung-Yi Chiou, Chao A Hsiung
Causal associations between type 1 diabetes and COVID-19 infection and prognosis: a two-sample Mendelian randomization study (13 June, 2023)
Xin-Ling Ma, Qi-Yun Shi, Qi-Gang Zhao, Qian Xu, Shan-Shan Yan, Bai-Xue Han, Chen Fang, Lei Zhang, Yu-Fang Pei
Food insecurity, SNAP participation and glycemic control in low-income adults with predominantly type 2 diabetes: a cross-sectional analysis using NHANES 2007–2018 data (23 May, 2023)
Oluwatobi Alawode, Sarah Humble, Cynthia J Herrick
Variations in all-cause mortality, premature mortality and cause-specific mortality among persons with diabetes in Ontario, Canada (2 May, 2023)
Laura C Rosella, Kathy Kornas, Ednah Negatu, Limei Zhou

Emerging technologies, pharmacology and therapeutics

Strains of Faecalibacterium prausnitzii and its extracts reduce blood glucose levels, percent HbA1c, and improve glucose tolerance without causing hypoglycemic side effects in diabetic and prediabetic mice
(5 June, 2023)
John Kallassy, Emily Gagnon, Dawn Rosenberg, Lawrence K Silbart, Simon A McManus

Genetics/Genomes/Proteomics/Metabolomics

Presence of PD-1 similarity genes in monocytes may promote the development of type 1 diabetes mellitus and poor prognosis of pancreatic cancer (2 May, 2023)
Yuquan Huang, Wenchuan Zhang, Can Xu, Qingxia Li, Wu Zhang, Wanfeng Xu, Mingming Zhang

Letter

Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study (16 June, 2023)
Stephen C Bain, Bendix Carstensen, Liselotte Hyveled, Stephanie Seremetis, Frederik Flindt Kreiner, Hanan Amadid, Alice Clark

Metabolism

Non-efficacy of early intervention strategy for non-obese patients with early-onset gestational diabetes mellitus: solely based on the short-term outcomes (2 June, 2023)
Sayuri Nakanishi, Shigeru Aoki, Junko Kasai, Ryosuke Shindo, Soichiro Obata, Yoshimi Hasegawa, Aya Mochimaru, Kentaro Kurasawa, Etsuko Miyagi
Fecal microbiota transplantation ameliorates type 2 diabetes via metabolic remodeling of the gut microbiota in db/db mice (30 May, 2023)
Lijuan Chen, Lin Guo, Susu Feng, Congcong Wang, Zhicheng Cui, Sijing Wang, Qingmiao Lu, Hang Chang, Bo Hang, Antoine M Snijders, Jian-Hua Mao, Yibing Lu, Dafa Ding

Obesity studies

Study design and baseline profile for adults with type 2 diabetes in the once-weekly subcutaneous SEmaglutide randomized PRAgmatic (SEPRA) trial (3 May, 2023)
John B Buse, Helene Nordahl Christensen, Brian J Harty, Julie Mitchell, Benjamin P Soule, Emily Zacherle, Mark Cziraky, Vincent J Willey

Pathophysiology/complications

Decreased branched-chain amino acids and elevated fatty acids during antecedent hypoglycemia in type 1 diabetes (27 June, 2023)
Rui She, Naba Hassan Al-sari, Ismo Matias Mattila, Anne-Sophie Sejling, Jens Pedersen, Cristina Legido-Quigley, Ulrik Pedersen-Bjergaard
‘You have to use everything and come to some equilibrium’: a qualitative study on hypoglycemia self-management in users of continuous glucose monitor with diverse hypoglycemia experiences (22 June, 2023)
Yu Kuei Lin, Annika Agni, Samantha Chuisano, Nicole de Zoysa, Michael Fetters, Stephanie A Amiel, Rodica Pop-Busui, Melissa DeJonckheere
Patients with prediabetes are at greater risk of developing diabetes 5 months postacute SARS-CoV-2 infection: a retrospective cohort study (9 June, 2023)
Alexander Y. Xu, Stephen H. Wang, Tim Q. Duong

Correction

Correction: Insulin resistance based on postglucose load measure is associated with prevalence and burden of cerebral small vessel disease (12 May, 2023)

Main menu

Table of contents

2023 - Volume 11 - 3

Cardiovascular and metabolic risk

Epidemiology/Health services research

Emerging technologies, pharmacology and therapeutics

Genetics/Genomes/Proteomics/Metabolomics

Letter

Metabolism

Obesity studies

Pathophysiology/complications

Correction

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

2023 - Volume 11 - 3

Cardiovascular and metabolic risk

Epidemiology/Health services research

Emerging technologies, pharmacology and therapeutics

Genetics/Genomes/Proteomics/Metabolomics

Letter

Metabolism

Obesity studies

Pathophysiology/complications

Correction